Source: Virtual Congress 2020 – Screening and imaging in lung cancer
Disease area: Thoracic oncology



Rating:

Share or cite this content

Citations should be made in the following way:
C. Simsek (Ankara, Turkey), B. Uzmezoglu (Ankara, Turkey), O. Algin (Ankara, Turkey), G. Sari (Ankara, Turkey). A comparison of MRI findings in cases with progressive massive fibrosis and lung cancer. 4170

Member's Comments

No comment yet.

Related content which might interest you: Autopsy findings in 42 consecutive patients with idiopathic pulmonary fibrosis Source: Eur Respir J 2008; 32: 170-174 Year: 2008 Lung cancer in patients with idiopathic pulmonary fibrosis Source: Eur Respir J 2001; 17: 1216-1219 Year: 2001 The correlation between pathological findings of transbronchial lung cryobiopsy and high resolution CT morphology for diffuse parenchymal lung disease patients Source: International Congress 2018 – What is new in idiopathic interstitial pneumonias? Year: 2018 Comparison of clinical features between patients of lung cancer with combined pulmonary fibrosis and emphysema syndrome and those with interstitial pneumonia Source: Annual Congress 2012 - Diffuse parenchymal lung disease II Year: 2012 A prospective evaluation of lung ultrasonography in patients with fibrotic interstitial lung diseases; preliminary results. Source: International Congress 2018 – News on the diagnosis of idiopathic interstitial pneumonia Year: 2018 A prospective evaluation of lung ultrasonography in patients with fibrotic interstitial lung diseases. Source: Virtual Congress 2021 – News in treatment and diagnosis of idiopathic interstitial pneumonia Year: 2021 MRI metric lung parenchyma T1 indicates lung pathology in patients with pulmonary hypertension. Source: Virtual Congress 2021 – Therapy of pulmonary hypertension Year: 2021 Surgical biopsy results of our patients with diffuse parenchymal lung diseases Source: International Congress 2018 – Clinical aspects of hypersensitivity pneumonitis (HP) and CTD-ILD: diagnosis, monitoring and treatment Year: 2018 Paradoxically normal lung volume assessed by CXR and total lung capacity in patients with diffuse pulmondary fibrosis and additional emphysema Source: Eur Respir J 2006; 28: Suppl. 50, 98s Year: 2006 Clinical and molecular analysis of lung cancer associated with fibrosing and diffuse interstitial lung disease. Source: Virtual Congress 2021 – New clinical and biological developments in lung cancer Year: 2021 A study on chemotherapy induced interstitial lung disease in patients with unresectable non-small cell lung cancer complicated by combined pulmonary fibrosis and emphysema Source: Annual Congress 2012 - Treatment of lung cancer Year: 2012 3he MRI and an animal model of interstitial lung disease Source: Annual Congress 2009 - Chest imaging in evolution: new techniques and new possibilities Year: 2009 Neurofibromatosis-associated lung disease: a case series and literature review Source: Eur Respir J 2007; 29: 210-214 Year: 2007 A case series study on re-treatment to lung cancer after drug-induced interstitial lung disease Source: International Congress 2018 – CTD-ILD and hypersensitivity pneumonitis: from the bench to the bedside Year: 2018 Progression of structural lung damage on high resolution CT in cystic fibrosis children with stable lung function Source: Eur Respir J 2002; 20: Suppl. 38, 209s Year: 2002 The clinical value of surgical lung biopsy in 166 patients with suspected interstitial lung disease Source: International Congress 2015 – New insights into IIPs Year: 2015 Computed-tomography-based radiomics features for staging of interstitial lung disease – transferability from experimental to human lung fibrosis - a proof-of-concept study Source: International Congress 2019 – Imaging for prognostication and disease characterisation: 2019 update Year: 2019 Analyses of predictive findings indicative of progressive interstitial lung diseases Source: Virtual Congress 2021 – Prognostic markers of disease progression in non-idiopathic pulmonary fibrosis interstitial lung diseases Year: 2021 Biological- and imaging biomarkers of edema and fibrosis in a rat model of drug-induced interstitial lung disease (DIILD) Source: International Congress 2019 – New mechanistic insights into pulmonary fibrosis Year: 2019